Cargando…
Long-Term Outcome of Patients with TPO Mutations
Introduction: Thyroid peroxidase (TPO) deficiency is the most common enzymatic defect causing congenital hypothyroidism (CH). We aimed to characterize the long-term outcome of patients with TPO deficiency. Methods: Clinical and genetic data were collected retrospectively. Results: Thirty-three patie...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432017/ https://www.ncbi.nlm.nih.gov/pubmed/34501348 http://dx.doi.org/10.3390/jcm10173898 |
_version_ | 1783751066725122048 |
---|---|
author | Tobias, Leraz Elias-Assad, Ghadir Khayat, Morad Admoni, Osnat Almashanu, Shlomo Tenenbaum-Rakover, Yardena |
author_facet | Tobias, Leraz Elias-Assad, Ghadir Khayat, Morad Admoni, Osnat Almashanu, Shlomo Tenenbaum-Rakover, Yardena |
author_sort | Tobias, Leraz |
collection | PubMed |
description | Introduction: Thyroid peroxidase (TPO) deficiency is the most common enzymatic defect causing congenital hypothyroidism (CH). We aimed to characterize the long-term outcome of patients with TPO deficiency. Methods: Clinical and genetic data were collected retrospectively. Results: Thirty-three patients with primary CH caused by TPO deficiency were enrolled. The follow-up period was up to 43 years. Over time, 20 patients (61%) developed MNG. Eight patients (24%) underwent thyroidectomy: one of them had minimal invasive follicular thyroid carcinoma. No association was found between elevated lifetime TSH levels and the development of goiter over the years. Conclusions: This cohort represents the largest long-term follow up of patients with TPO deficiency. Our results indicate that elevated TSH alone cannot explain the high rate of goiter occurrence in patients with TPO deficiency, suggesting additional factors in goiter development. The high rate of MNG development and the risk for thyroid carcinoma indicate a need for long-term follow up with annual ultrasound scans. |
format | Online Article Text |
id | pubmed-8432017 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84320172021-09-11 Long-Term Outcome of Patients with TPO Mutations Tobias, Leraz Elias-Assad, Ghadir Khayat, Morad Admoni, Osnat Almashanu, Shlomo Tenenbaum-Rakover, Yardena J Clin Med Article Introduction: Thyroid peroxidase (TPO) deficiency is the most common enzymatic defect causing congenital hypothyroidism (CH). We aimed to characterize the long-term outcome of patients with TPO deficiency. Methods: Clinical and genetic data were collected retrospectively. Results: Thirty-three patients with primary CH caused by TPO deficiency were enrolled. The follow-up period was up to 43 years. Over time, 20 patients (61%) developed MNG. Eight patients (24%) underwent thyroidectomy: one of them had minimal invasive follicular thyroid carcinoma. No association was found between elevated lifetime TSH levels and the development of goiter over the years. Conclusions: This cohort represents the largest long-term follow up of patients with TPO deficiency. Our results indicate that elevated TSH alone cannot explain the high rate of goiter occurrence in patients with TPO deficiency, suggesting additional factors in goiter development. The high rate of MNG development and the risk for thyroid carcinoma indicate a need for long-term follow up with annual ultrasound scans. MDPI 2021-08-30 /pmc/articles/PMC8432017/ /pubmed/34501348 http://dx.doi.org/10.3390/jcm10173898 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tobias, Leraz Elias-Assad, Ghadir Khayat, Morad Admoni, Osnat Almashanu, Shlomo Tenenbaum-Rakover, Yardena Long-Term Outcome of Patients with TPO Mutations |
title | Long-Term Outcome of Patients with TPO Mutations |
title_full | Long-Term Outcome of Patients with TPO Mutations |
title_fullStr | Long-Term Outcome of Patients with TPO Mutations |
title_full_unstemmed | Long-Term Outcome of Patients with TPO Mutations |
title_short | Long-Term Outcome of Patients with TPO Mutations |
title_sort | long-term outcome of patients with tpo mutations |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432017/ https://www.ncbi.nlm.nih.gov/pubmed/34501348 http://dx.doi.org/10.3390/jcm10173898 |
work_keys_str_mv | AT tobiasleraz longtermoutcomeofpatientswithtpomutations AT eliasassadghadir longtermoutcomeofpatientswithtpomutations AT khayatmorad longtermoutcomeofpatientswithtpomutations AT admoniosnat longtermoutcomeofpatientswithtpomutations AT almashanushlomo longtermoutcomeofpatientswithtpomutations AT tenenbaumrakoveryardena longtermoutcomeofpatientswithtpomutations |